<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0051">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Zhang</surname>
    <given-names>H.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Penninger</surname>
    <given-names>J. M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Li</surname>
    <given-names>Y.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhong</surname>
    <given-names>N.</given-names>
   </name>, &amp; 
   <name name-style="western">
    <surname>Slutsky</surname>
    <given-names>A. S.</given-names>
   </name>
  </person-group> (
  <year>2020</year>). 
  <article-title>Angiotensin-Converting Enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target</article-title>. 
  <source>
   <italic toggle="yes">Intensive Care Medicine</italic>
  </source>, (
  <issue>4</issue>), 
  <fpage>586</fpage>â€“
  <lpage>590</lpage>. 
  <pub-id pub-id-type="doi">10.1007/s00134-020-05985-9</pub-id>
  <pub-id pub-id-type="pmid">32125455</pub-id>
 </mixed-citation>
</ref>
